Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21104861rdf:typepubmed:Citationlld:pubmed
pubmed-article:21104861lifeskim:mentionsumls-concept:C0442874lld:lifeskim
pubmed-article:21104861lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:21104861lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:21104861lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:21104861lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:21104861lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:21104861pubmed:issue6lld:pubmed
pubmed-article:21104861pubmed:dateCreated2010-11-24lld:pubmed
pubmed-article:21104861pubmed:abstractTextTo better understand the presumed immune system dysregulation of chronic dysimmune neuropathy (CDN) patients, we designed a study to evaluate the levels of pro- and anti-inflammatory cytokines in the most common forms of CDN: chronic inflammatory demyelinating polyneuropathy (CIDP), and anti-myelin-associated glycoprotein (MAG)-related polyneuropathy (MAGnp). Sixteen patients fulfilled diagnostic criteria for CIDP, 14 were diagnosed with MAGnp, and 36 were classified as exhibiting "chronic idiopathic polyneuropathy" (CIP). Cytokine production in mitogen-stimulated peripheral blood mononuclear cells (PBMCs) was analyzed by flow cytometry. CIDP and MAGnp patients were compared with CIP patients, those with monoclonal gammopathy without polyneuropathy (MGUS), and healthy controls (HC). We observed an increase in pro-inflammatory cytokines in the CIDP group, whereas interleukin-10 (IL-10) was augmented in the MAGnp patients. These distinctive immune alterations may represent a biological tool in differential diagnosis and future therapeutic approaches.lld:pubmed
pubmed-article:21104861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21104861pubmed:languageenglld:pubmed
pubmed-article:21104861pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21104861pubmed:citationSubsetIMlld:pubmed
pubmed-article:21104861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21104861pubmed:statusMEDLINElld:pubmed
pubmed-article:21104861pubmed:monthDeclld:pubmed
pubmed-article:21104861pubmed:issn1097-4598lld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:ClericiMarioMlld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:AntoniniGiova...lld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:BeghiEttoreElld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:GironiMairaMlld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:MorinoStefani...lld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:SaresellaMari...lld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:GattiAndreaAlld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:NemniRaffaell...lld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:GueriniFranca...lld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:MarventanoIva...lld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:CeresaLaraLlld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:MarianiEnrica...lld:pubmed
pubmed-article:21104861pubmed:authorpubmed-author:AngeliciAlber...lld:pubmed
pubmed-article:21104861pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21104861pubmed:volume42lld:pubmed
pubmed-article:21104861pubmed:ownerNLMlld:pubmed
pubmed-article:21104861pubmed:authorsCompleteYlld:pubmed
pubmed-article:21104861pubmed:pagination864-70lld:pubmed
pubmed-article:21104861pubmed:dateRevised2011-7-12lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:meshHeadingpubmed-meshheading:21104861...lld:pubmed
pubmed-article:21104861pubmed:year2010lld:pubmed
pubmed-article:21104861pubmed:articleTitleDistinct cytokine patterns associated with different forms of chronic dysimmune neuropathy.lld:pubmed
pubmed-article:21104861pubmed:affiliationDepartment of Neurology, Don C. Gnocchi Foundation IRCCS, Milan, Italy.lld:pubmed
pubmed-article:21104861pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21104861pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:21104861lld:pubmed